SCHEMBL1131499

SCHEMBL1131499

C/C(=C\C(=O)O)c1nn(C2CCCCC2)c(-c2ccc(O)cc2)c1-c1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 3/20 0.48
HPGD P15428 1/20 0.41
ESR1 P03372 3/20 0.40
KCNJ6 P48051 6/20 0.38
KCNJ3 P48549 6/20 0.38
KCNJ5 P48544 4/20 0.38
AURKA O14965 1/20 0.35
CCNA2 P20248 1/20 0.35
CDK2 P24941 1/20 0.35
PLK1 P53350 1/20 0.35
CCNA1 P78396 1/20 0.35
CNR2 P34972 1/20 0.35
HTR2A P28223 1/20 0.35
HTR2C P28335 1/20 0.35
HTR2B P41595 1/20 0.35
ALOX5 P09917 1/20 0.35
MAT2A P31153 1/20 0.35
MAPK13 O15264 1/20 0.33
MAPK12 P53778 1/20 0.33
MAPK11 Q15759 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1132023 0.87 CNR1 (0.42) CNR1KCNJ6KCNJ3KCNJ5
SCHEMBL1131504 0.79 CNR1 (0.43) CNR1HPGDESR1KCNJ6KCNJ3
SCHEMBL3887467 0.79 ALOX5 (0.45) CNR1HPGDESR1KCNJ6KCNJ3
SCHEMBL3887462 0.79 ALOX5 (0.45) CNR1HPGDESR1KCNJ6KCNJ3
SCHEMBL1131589 0.77 CNR1 (0.40) CNR1
SCHEMBL1131498 0.75 CNR1 (0.43) CNR1HPGDESR1KCNJ6KCNJ3
SCHEMBL1131500 0.75 CNR1 (0.43) CNR1HPGDESR1KCNJ6KCNJ3
SCHEMBL1131608 0.74 ESR1 (0.40) ESR1KCNJ6KCNJ3KCNJ5
SCHEMBL5215880 0.74 ESR1 (0.52) CNR1HPGDESR1HTR2AHTR2C
SCHEMBL1132025 0.68 PTPN1 (0.43) CNR1HPGDKCNJ6KCNJ3KCNJ5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1663105-B1 CYCLOALKYL HETEROCYCLES FOR TREATING HEPATITIS C VIRUS BRISTOL MYERS SQUIBB CO (US) 2011-02-16 EP disclosed